{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:38:19Z","timestamp":1793414299701,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,27]]},"DOI":"10.1097\/01.tp.0000226171.43943.d3","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T10:03:07Z","timestamp":1153303387000},"page":"147-153","source":"Crossref","is-referenced-by-count":49,"title":["Costs of Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1097","volume":"82","author":[{"given":"Britt-Marie","family":"Svahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Alvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Gardulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V59.2.236.236","article-title":"Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.","volume":"59","author":"Storb","year":"1982","journal-title":"Blood"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/02841869709001316","article-title":"Allogeneic bone marrow transplantation for hematological malignancies - controversies and recent advances.","volume":"36","author":"Ringd\u00e9n","year":"1997","journal-title":"Acta Oncologica"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Haematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practic guidelines.","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R6-1-20210129","first-page":"323","article-title":"Comparative cost af allogenic or autologous bone marrow transplantation and chemotherapu in patients with acute myeloid leukaemia in first remission.","volume":"10","author":"Dufoir","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.1996.14.5.1413","article-title":"Economic evaluation of allogeneic bone marrow transplantation: a rudimentary model to generate estimates for the timely formlation of clinical policy.","volume":"14","author":"Barr","year":"1996","journal-title":"J Clin Oncol"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood.V92.11.4047","article-title":"The cost and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukaemia.","volume":"92","author":"Lee","year":"1998","journal-title":"Blood"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","article-title":"Predicting costs of stem cell transplantation.","volume":"18","author":"Lee","year":"2000","journal-title":"J Clin Oncol"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bmt.1703310","article-title":"A prospective cost evaluation related to allogeneic haematopoietic stem cell transplantation including pretransplant procedures, transplantation and 1-year follow-up procedures.","volume":"28","author":"Mishra","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","article-title":"Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis and alopecia using busulfan compared to total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia.","volume":"93","author":"Ringd\u00e9n","year":"1999","journal-title":"Blood"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V81.4.1094.1094","article-title":"Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?","volume":"81","author":"Ringd\u00e9n","year":"1993","journal-title":"Blood"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-199410270-00005","article-title":"Long-term follow-up of a randomized trial comparing T-cell-depletion with a combination of methotrexate and cyclosporin in adult leukemic marrow transplant recipients.","volume":"58","author":"Ringd\u00e9n","year":"1994","journal-title":"Transplantation"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","article-title":"Effect on cytokine release and graft-versus-host disease of different anti-T-cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.","volume":"24","author":"Remberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","article-title":"Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared to hospital care.","volume":"100","author":"Svahn","year":"2002","journal-title":"Blood"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1704108","article-title":"G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.","volume":"32","author":"Remberger","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","article-title":"Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukaemia increases the risk of graft-versus-host disease and death.","volume":"22","author":"Ringd\u00e9n","year":"2004","journal-title":"J Clin Oncol"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/bbmt.1999.v5.pm10465099","article-title":"Mixed chimerism: preclinical studies and clinical applications.","volume":"5","author":"McSweeney","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1703811","article-title":"Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.","volume":"31","author":"Hentschke","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"R23-1-20210129","first-page":"3530","article-title":"Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.","volume":"27","author":"Sparrelid","year":"1995","journal-title":"Transplant Proc"},{"key":"R24-1-20210129","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.","volume":"15","author":"Ringd\u00e9n","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bmt.1701650","article-title":"Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation.","volume":"23","author":"Abecasis","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1702387","article-title":"N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.","volume":"25","author":"Ringd\u00e9n","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(84)92848-4","article-title":"Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.","volume":"i","author":"Prentice","year":"1984","journal-title":"Lancet"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia.","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705078","article-title":"Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-Cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.","volume":"36","author":"de Lissovoy","year":"2005","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200607270-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:01:48Z","timestamp":1618030908000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200607270-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,27]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000226171.43943.d3","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7,27]]}}}